(1) This act shall not be construed to expand the coverage required of an insurer under Title 83 of the Mississippi Code. (2) A health plan, third party administrator, or governmental agency may, but is not required to, provide coverage for the cost of an individualized investigational drug, biological product, or device, or the cost of services related to the use of an individualized investigational drug, biological product, or device under this act. (3) This act shall not be construed to require any governmental agency to pay costs associated with the use, care, or treatment of a patient with an individualized investigational drug, biological product, or device. (4) This act shall not be construed to require a licensed hospital or facility to provide new or additional services, unless approved by the hospital or facility. Added by Laws, 2024, ch. 432, SB 2858,§ 3, eff. 7/1/2024. (1) This act shall not be construed to expand the coverage required of an insurer under Title 83 of the Mississippi Code. (2) A health plan, third party administrator, or governmental agency may, but is not required to, provide coverage for the cost of an individualized investigational drug, biological product, or device, or the cost of services related to the use of an individualized investigational drug, biological product, or device under this act. (3) This act shall not be construed to require any governmental agency to pay costs associated with the use, care, or treatment of a patient with an individualized investigational drug, biological product, or device. (4) This act shall not be construed to require a licensed hospital or facility to provide new or additional services, unless approved by the hospital or facility. Added by Laws, 2024, ch. 432, SB 2858,§ 3, eff. 7/1/2024. (1) This act shall not be construed to expand the coverage required of an insurer under Title 83 of the Mississippi Code. (2) A health plan, third party administrator, or governmental agency may, but is not required to, provide coverage for the cost of an individualized investigational drug, biological product, or device, or the cost of services related to the use of an individualized investigational drug, biological product, or device under this act. (3) This act shall not be construed to require any governmental agency to pay costs associated with the use, care, or treatment of a patient with an individualized investigational drug, biological product, or device. (4) This act shall not be construed to require a licensed hospital or facility to provide new or additional services, unless approved by the hospital or facility. Added by Laws, 2024, ch. 432, SB 2858,§ 3, eff. 7/1/2024. (1) This act shall not be construed to expand the coverage required of an insurer under Title 83 of the Mississippi Code. (2) A health plan, third party administrator, or governmental agency may, but is not required to, provide coverage for the cost of an individualized investigational drug, biological product, or device, or the cost of services related to the use of an individualized investigational drug, biological product, or device under this act. (3) This act shall not be construed to require any governmental agency to pay costs associated with the use, care, or treatment of a patient with an individualized investigational drug, biological product, or device. (4) This act shall not be construed to require a licensed hospital or facility to provide new or additional services, unless approved by the hospital or facility.
‹ Prev All Mississippi sections Next ›
Lexace provides legal information, not legal advice, and no attorney–client relationship is created. Statute text is provided for general information and may not reflect the most recent amendments; verify against the official state code.